Arsenal Sign Another Youngster

The Professor has signed a midfielder, but not the big name we're expecting; a kid I've never heard of before.

Arsenal have signed Portugal Under-21 midfielder Amaury Bischoff from Werder Bremen for an undisclosed fee. The 21-year-old made just one appearance for the Budesliga side Bremen

last season and he can play in the centre or right of midfield.

Ok. I agree we need someone to plug Flamini's role (I'm not sold that Diaby is the answer, yet), but the biggest wish on my list is a big, strong central defender. Toure and Gallas are great defenders, but they're not the answer in the middle. Take one of them and pair with a dominant, physical player. Our biggest weakness last year was the center of the defense and Arsene hasn't done anything to address that.

Hleb is Going, Going, Gone

Crazy-legs is on his way out the door. This has been coming for awhile, but I'm beginning to grow nervous about the midfield. Two of the starters are gone, with Flamini already shifting out. The center has softened with his departure. And Hleb often played a roving, linking role with Adebayor (who, also, may be gone in the NDF). Arsene, what are your plans, sir?

Puppy Uppers & Doggy Downers

Gone are the days when an old pet was a pet to be put down. Now, not only can we (and do we!) lavish expensive medical care on our pets, we can also buy them the best pharmacologicals that money can buy - and they're chewable, too!

clipped from www.nytimes.com The practice of prescribing medications designed for humans to animals has grown substantially over the past decade and a half, and pharmaceutical companies have recently begun experimenting with a more direct strategy: marketing behavior-modification and “lifestyle” drugs specifically for pets. America’s animals, it seems, have very American health problems. More than 20 percent of our dogs are overweight; Pfizer’s Slentrol was approved by the F.D.A. last year as the country’s first canine anti-obesity medication. Dogs live 13 years on average, considerably longer than they did in the past; Pfizer’s Anipryl treats cognitive dysfunction so that absent-minded pets can remember the location of the supper bowl or doggy door. For lonely dogs with separation anxiety, Eli Lilly brought to market its own drug Reconcile last year. The only difference between it and Prozac is that Reconcile is chewable and tastes like beef.